Option Care Health Announces Preliminary Fourth Quarter & Full Year 2025 Financial Results and Preliminary Financial Guidance for Full Year 2026
OPCHBANNOCKBURN, Ill., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2025, and preliminary financial guidance for the full year 2026.
Option Care Health To Participate in Upcoming Investor Conferences
OPCHBANNOCKBURN, Ill., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will participate in the following upcoming investor conferences:
Option Care Health Announces Chief Financial Officer Transition
OPCHMike Shapiro to Step Down After 10 Years With the Company; Meenal Sethna Named EVP and CFO Effective October 1, 2025
Mike Shapiro to Step Down After 10 Years With the Company; Meenal Sethna Named EVP and CFO Effective October 1, 2025
A Look Into Option Care Health Inc's Price Over Earnings
OPCH$1000 Invested In Option Care Health 5 Years Ago Would Be Worth This Much Today
OPCHWhat Does the Market Think About Option Care Health?
OPCHIf You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today
OPCHBarrington Research Maintains Outperform on Option Care Health, Maintains $38 Price Target
OPCHUBS Upgrades Option Care Health to Buy, Raises Price Target to $40
OPCHOption Care Health Raises FY2025 Adj EPS Guidance from $1.59-$1.69 to $1.61-$1.70 vs $1.46 Est; Raises FY2025 Sales Guidance from $5.30B-$5.50B to $5.40B-$5.60B vs $5.43B Est
OPCHOption Care Health Q1 Adj. EPS $0.40 Beats $0.30 Estimate, Sales $1.33B Beat $1.26B Estimate
OPCHPeering Into Option Care Health's Recent Short Interest
OPCHJMP Securities Reiterates Market Outperform on Option Care Health, Maintains $36 Price Target
OPCHBreaking Down Option Care Health: 5 Analysts Share Their Views
OPCHBarrington Research Maintains Outperform on Option Care Health, Maintains $38 Price Target
OPCHHere's How Much You Would Have Made Owning Option Care Health Stock In The Last 5 Years
OPCHJP Morgan Maintains Overweight on Option Care Health, Raises Price Target to $41
OPCH6 Analysts Assess Option Care Health: What You Need To Know
OPCHBarrington Research Maintains Outperform on Option Care Health, Raises Price Target to $38
OPCHOption Care Health Sees FY25 Revenue $5.3B-$5.5B vs $5.262B Est., Adj. EPS $1.59-$1.69 vs $1.25 Est., Adj. EBITDA $450M-$470M.
OPCHOption Care Health Q4 2024 Adj. EPS $0.44 Beats $0.34 Estimate, Sales $1.346B Beat $1.289B Estimate
OPCHBarrington Research Maintains Outperform on Option Care Health, Raises Price Target to $33
OPCHOption Care Health Expects Preliminary FY25 Net Revenue Of $5.2B - $5.4B (Est $5.233B), Adjusted EPS Of $1.59 - $1.69 (Est $1.24)
OPCHOption Care Health Expects FY24 Net Revenue Of $4.99B - $5.00B (Est $4.922B), Adjusted EPS Of $1.55 - $1.59 (Est $1.21)
OPCHOption Care Health Expects Q4 Net Revenue Of $1.34B - $1.35B, Est $1.27B; Adjusted EPS Of $0.42 - $0.45 (Est $0.33)
OPCHOption Care Health Board Approves New $500M Stock Repurchase Program
OPCHAssessing Option Care Health: Insights From 7 Financial Analysts
OPCHJMP Securities Reiterates Market Outperform on Option Care Health, Lowers Price Target to $30
OPCHGoldman Sachs Downgrades Option Care Health to Neutral, Lowers Price Target to $27
OPCHNavigating 5 Analyst Ratings For Option Care Health
OPCHTruist Securities Maintains Buy on Option Care Health, Lowers Price Target to $34
OPCHBarrington Research Maintains Outperform on Option Care Health, Lowers Price Target to $32
OPCHJefferies Downgrades Option Care Health to Hold, Lowers Price Target to $26
OPCHOption Care Health: Q1 Earnings Insights
OPCHOption Care Health (NASDAQ:OPCH) reported its Q1 earnings results on Thursday, April 28, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
Option Care Health Sees FY22 Sales $3.75B-$3.90B Vs. $3.74B Est., Adj. EBITDA $320M-$335M
OPCHOption Care Health Q1 EPS $0.17 Beats $0.13 Estimate, Sales $915.80M Beat $839.39M Estimate
OPCH